Current advances in biomarkers for targeted therapy in triple-negative breast cancer
Abstract: Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Revisão |
| Reo: | Ingarihi |
| I whakaputaina: |
2016
|
| Urunga tuihono: | https://doi.org/10.2147/bctt.s114659 https://www.dovepress.com/getfile.php?fileID=32807 |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|